Profile data is unavailable for this security.
About the company
EBOS Group Limited is an Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also an Australasian animal care brand owner, product marketer, and distributor. Its segments include Healthcare, Animal Care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, such as own brands, retail healthcare, medical devices, capital equipment, pharmacy services, and wholesale activities. The Animal Care segment incorporates the sale of animal care products in a range of sectors, own brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid, TerryWhite Chemmart, and Pharmacy Wholesalers Russells, among others. Its Contract Logistics business includes Healthcare Logistics and Healthcare Logistics Clinical Trials. Its Institutional Healthcare includes Clinect, Cryomed Aesthetics and Onelink, among others.
- Revenue in NZD (TTM)12.19bn
- Net income in NZD230.08m
- Incorporated1922
- Employees3.99k
- LocationEBOS Group Ltd108 Wrights RoadCHRISTCHURCH 8024New ZealandNZL
- Phone+64 33380999
- Fax+64 33395090
- Websitehttp://www.ebosgroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Herbalife Nutrition Ltd | 9.68bn | 601.45m | 3.79bn | 10.80k | 6.03 | -- | 4.74 | 0.3917 | 3.30 | 3.30 | 53.18 | -14.47 | 1.90 | 2.24 | 57.42 | 507,166.70 | 11.80 | 12.70 | 18.77 | 20.85 | 77.64 | 79.97 | 6.21 | 7.03 | 0.8306 | 4.39 | 2.01 | 0.00 | 4.71 | 5.27 | 20.02 | 11.46 | 1.09 | -- |
| SUZUKEN CO., LTD. | 27.37bn | 213.18m | 4.16bn | 14.03k | 16.62 | 0.6938 | 12.75 | 0.152 | 198.92 | 198.92 | 25,546.67 | 4,763.78 | 1.93 | 14.74 | 4.24 | 160,161,400.00 | 1.50 | 1.75 | 3.95 | 4.59 | 7.46 | 8.21 | 0.7799 | 0.9239 | 1.05 | -- | 0.00 | 31.84 | 4.91 | 0.9754 | 82.31 | -7.55 | 2.14 | 5.92 |
| Alfresa Holdings Corporation | 31.65bn | 378.29m | 4.17bn | 11.93k | 11.28 | 0.7197 | 7.77 | 0.1319 | 149.77 | 149.77 | 12,542.83 | 2,348.24 | 1.95 | 16.38 | 4.25 | 217,960,500.00 | 2.34 | 2.63 | 6.06 | 7.04 | 7.18 | 7.40 | 1.20 | 1.33 | 1.07 | -- | 0.00006 | 29.60 | -0.9494 | 0.2638 | 31.35 | 0.8209 | 4.54 | 8.45 |
| China Medicine Health Industry Co Ltd | 8.85bn | 149.53m | 4.47bn | 8.72k | 29.92 | 1.69 | -- | 0.5056 | 0.4025 | 0.4025 | 23.81 | 7.14 | 1.11 | 5.28 | 2.85 | 4,087,266.00 | 2.08 | 5.00 | 4.30 | 11.55 | 13.46 | 16.44 | 1.88 | 3.93 | 1.31 | 8.75 | 0.3572 | 37.30 | -7.83 | 6.91 | -50.63 | -7.39 | 12.03 | -0.9072 |
| China National Medicines Corporation Ltd | 11.52bn | 459.61m | 4.67bn | 3.01k | 10.16 | 1.43 | -- | 0.4051 | 2.45 | 2.45 | 61.50 | 17.38 | 1.73 | 12.07 | 7.75 | 15,440,710.00 | 7.58 | 7.31 | 15.63 | 16.30 | 7.73 | 8.19 | 4.37 | 3.99 | 1.70 | -- | 0.129 | 28.48 | 15.08 | 6.07 | 26.86 | 12.12 | 13.75 | 28.47 |
| China Medical System Holdings | 2.22bn | 791.57m | 5.17bn | 5.45k | 6.56 | 1.51 | 6.11 | 2.33 | 1.43 | 1.43 | 4.01 | 6.21 | 0.5671 | 4.30 | 6.72 | 1,863,021.00 | 20.23 | 19.28 | 23.45 | 21.83 | 76.15 | 72.57 | 35.67 | 34.39 | 2.94 | -- | 0.1232 | 40.07 | 20.03 | 11.21 | 19.25 | 17.01 | 23.23 | 16.47 |
| Jointown Pharmaceutical Group Co Ltd | 31.89bn | 391.04m | 5.32bn | 29.34k | 13.80 | 0.9826 | -- | 0.1669 | 0.829 | 0.829 | 65.43 | 12.70 | 1.47 | 8.32 | 3.77 | 4,376,941.00 | 1.95 | 3.19 | 6.31 | 9.83 | 7.59 | 8.53 | 1.33 | 2.15 | 1.03 | 2.73 | 0.5881 | 41.35 | 10.42 | 14.74 | -17.76 | 24.34 | 3.80 | -- |
| Medipal Holdings Corp | 40.24bn | 344.00m | 5.49bn | 12.80k | 14.61 | 0.718 | 8.64 | 0.1364 | 126.13 | 126.13 | 14,808.33 | 2,566.73 | 1.94 | 19.67 | 4.52 | 258,133,900.00 | 2.21 | 2.60 | 6.26 | 7.26 | 6.61 | 7.02 | 1.14 | 1.32 | 1.05 | -- | 0.0436 | 26.65 | 2.48 | 1.44 | 22.98 | 0.2824 | -12.03 | 7.26 |
| McKesson Europe AG | 35.72bn | -1.40bn | 7.10bn | 6.81k | -- | 2.19 | -- | 0.1989 | -3.97 | -4.76 | 101.58 | 9.22 | 2.76 | 12.95 | 9.14 | 3,032,271.00 | -10.77 | -1.29 | -22.17 | -2.87 | 10.30 | 10.23 | -3.90 | -0.6228 | 0.8985 | 6.20 | 0.4099 | -- | 8.68 | -14.82 | -2,039.29 | -- | -28.84 | 0.00 |
| EBOS Group Ltd | 12.19bn | 230.08m | 7.12bn | 3.99k | 28.80 | 2.77 | 22.10 | 0.5845 | 1.31 | 1.31 | 68.89 | 13.58 | 2.10 | 9.98 | 8.48 | 3,053,510.00 | 3.96 | 4.45 | 6.80 | 8.22 | 11.49 | 11.10 | 1.88 | 1.93 | 0.7742 | 18.23 | 0.4337 | 76.59 | 16.64 | 8.30 | 9.34 | 9.98 | 20.34 | 7.84 |
| China Resources Pharmaceutical Group Ltd | 55.85bn | 980.72m | 7.62bn | 62.00k | 7.77 | 0.67 | 3.14 | 0.1365 | 0.6933 | 0.6933 | 39.48 | 8.05 | 1.01 | 7.48 | 3.48 | 3,815,924.00 | 3.15 | 3.40 | 12.37 | 12.03 | 15.22 | 16.43 | 3.11 | 3.14 | 1.08 | 8.41 | 0.4514 | 21.87 | 18.15 | 8.61 | 14.31 | 5.96 | 10.58 | 10.76 |
Data as of Oct 07 2022. Currency figures normalised to EBOS Group Ltd's reporting currency: New Zealand Dollar NZD
15.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harbour Asset Management Ltd.as of 01 Sep 2021 | 5.32m | 2.81% |
| Accident Compensation Corp.as of 16 Jul 2021 | 4.91m | 2.59% |
| The Vanguard Group, Inc.as of 09 Sep 2022 | 3.85m | 2.03% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 2.88m | 1.52% |
| Guardians of New Zealand Superannuationas of 30 Jun 2021 | 2.78m | 1.47% |
| Capital Research & Management Co. (Global Investors)as of 30 Jun 2022 | 2.66m | 1.40% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2022 | 2.52m | 1.33% |
| FMR Investment Management (UK) Ltd.as of 31 Jul 2022 | 1.82m | 0.96% |
| Fidelity Management & Research Co. LLCas of 31 Jul 2022 | 905.55k | 0.48% |
| Dimensional Fund Advisors LPas of 08 Sep 2022 | 777.45k | 0.41% |
More ▼
Data from 30 Jun 2021 - 21 Sep 2022Source: FactSet Research Systems Inc.
